These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34729378)
1. Biodistribution of intravitreal Calkins DJ; Yu-Wai-Man P; Newman NJ; Taiel M; Singh P; Chalmey C; Rogue A; Carelli V; Ancian P; Sahel JA Mol Ther Methods Clin Dev; 2021 Dec; 23():307-318. PubMed ID: 34729378 [TBL] [Abstract][Full Text] [Related]
2. Absence of lenadogene nolparvovec DNA in a brain tumor biopsy from a patient in the REVERSE clinical study, a case report. Newman NJ; Schniederjan M; Mendoza PR; Calkins DJ; Yu-Wai-Man P; Biousse V; Carelli V; Taiel M; Rugiero F; Singh P; Rogue A; Sahel JA; Ancian P BMC Neurol; 2022 Jul; 22(1):257. PubMed ID: 35820885 [TBL] [Abstract][Full Text] [Related]
9. Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study. Vignal-Clermont C; Girmens JF; Audo I; Said SM; Errera MH; Plaine L; O'Shaughnessy D; Taiel M; Sahel JA BioDrugs; 2021 Mar; 35(2):201-214. PubMed ID: 33566264 [TBL] [Abstract][Full Text] [Related]
10. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. Koilkonda RD; Yu H; Chou TH; Feuer WJ; Ruggeri M; Porciatti V; Tse D; Hauswirth WW; Chiodo V; Boye SL; Lewin AS; Neuringer M; Renner L; Guy J JAMA Ophthalmol; 2014 Apr; 132(4):409-20. PubMed ID: 24457989 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A Newman NJ; Yu-Wai-Man P; Carelli V; Biousse V; Moster ML; Vignal-Clermont C; Sergott RC; Klopstock T; Sadun AA; Girmens JF; La Morgia C; DeBusk AA; Jurkute N; Priglinger C; Karanjia R; Josse C; Salzmann J; Montestruc F; Roux M; Taiel M; Sahel JA Front Neurol; 2021; 12():662838. PubMed ID: 34108929 [No Abstract] [Full Text] [Related]
13. Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial. Bouquet C; Vignal Clermont C; Galy A; Fitoussi S; Blouin L; Munk MR; Valero S; Meunier S; Katz B; Sahel JA; Thomasson N JAMA Ophthalmol; 2019 Apr; 137(4):399-406. PubMed ID: 30730541 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy. Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279 [TBL] [Abstract][Full Text] [Related]
15. Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence-modified adeno-associated virus induces visual loss and optic atrophy in mice. Yu H; Ozdemir SS; Koilkonda RD; Chou TH; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Lewin AS; Guy J Mol Vis; 2012; 18():1668-83. PubMed ID: 22773905 [TBL] [Abstract][Full Text] [Related]
20. Induction of rapid and highly efficient expression of the human ND4 complex I subunit in the mouse visual system by self-complementary adeno-associated virus. Koilkonda RD; Chou TH; Porciatti V; Hauswirth WW; Guy J Arch Ophthalmol; 2010 Jul; 128(7):876-83. PubMed ID: 20625049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]